| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 929 |
| Total Income - EUR | - | - | - | - | 0 | 355 | 12.288 | 12.257 | 12.219 | 13.062 |
| Total Expenses - EUR | - | - | - | - | 306 | 2.914 | 28.675 | 13.597 | 14.889 | 18.254 |
| Gross Profit/Loss - EUR | - | - | - | - | -306 | -2.559 | -16.388 | -1.341 | -2.670 | -5.192 |
| Net Profit/Loss - EUR | - | - | - | - | -306 | -2.559 | -16.388 | -1.341 | -2.670 | -5.192 |
| Employees | - | - | - | - | 0 | 0 | 1 | 1 | 2 | 2 |
Check the financial reports for the company - Biovidanj S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 2 | 99.815 | 85.401 | 73.428 | 61.005 | 48.531 |
| Current Assets | - | - | - | - | 7.776 | 103.923 | 13.980 | 10.668 | 9.630 | 9.551 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 3 | 96.480 | 9.620 | 10.665 | 9.628 | 9.548 |
| Cash | - | - | - | - | 7.773 | 257 | 2.015 | 2 | 2 | 2 |
| Shareholders Funds | - | - | - | - | -264 | -2.818 | -19.143 | -20.544 | -23.518 | -28.712 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 8.042 | 111.254 | 37.538 | 35.639 | 37.563 | 42.652 |
| Income in Advance | - | - | - | - | 0 | 95.302 | 80.987 | 69.000 | 56.590 | 44.141 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3700 - 3700" | |||||||||
| CAEN Financial Year |
3700
|
|||||||||
Comments - Biovidanj S.r.l.